Use of Artificial Intelligence-Guided Echocardiography to assIst cardiovascuLar Patient managEment
Recruiting
N/A
Interventional Study
Heart Failure
Valve Heart Disease
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 45 and older
- Sex
- Any
- Study type
- Interventional
- Purpose
- Diagnostic
- Participants needed
- 612 (estimated)
- Sponsor
- Baker Heart and Diabetes Institute · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Heart Failure and valvular heart disease are disproportionate problems in rural and remote Australia (RRA). Echocardiography is the best imaging investigation, and essential for management, but access to this essential test shows huge geographic variations, primarily because of dependence on expert acquisition. This trial seeks to demonstrate the effectiveness of artificial intelligence-based echo…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Age \>45 years
* eligible for Medicare
* exercise intolerance or cardiovascular (CV) risk factors
Exclusion Criteria:
* Known HF or HVD
* situations where cardio-protection is already indicated (eg. known CAD)
* comorbid conditions with life expectancy \<2 years
* inability …
Contacts